Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M142,918Revenue $M47,267Net Margin (%)13.0Z-Score3.0
Enterprise Value $M147,346EPS $2.0Operating Margin %19.5F-Score4
P/E(ttm))24.1Cash Flow Per Share $6.3Pre-tax Margin (%)18.5Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %1.8Quick Ratio1.7Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %20.3Current Ratio2.3Lower Leverage y-yN
Price/Cash Flow7.1y-y EBITDA Growth Rate %-0.6ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %3.6Insider Buy (3m)0ROE % (ttm)11.6Less Shares Outstanding y-yN
Payout Ratio %100Shares Outstanding M3,022ROI % (ttm)16.6Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKJames Barrow 2013-03-31 Add0.99%$40.85 - $45.04
($42.8)
$ 47.1610%Add 38917.3%12,483,576
MRKLeon Cooperman 2013-03-31 Add0.9%$40.85 - $45.04
($42.8)
$ 47.1610%Add 225.64%1,921,300
MRKJean-Marie Eveillard 2013-03-31 Add0.23%$40.85 - $45.04
($42.8)
$ 47.1610%Add 10846%1,537,919
MRKRay Dalio 2013-03-31 Add0.02%$40.85 - $45.04
($42.8)
$ 47.1610%Add 117.35%95,941
MRKJoel Greenblatt 2013-03-31 Reduce-0.07%$40.85 - $45.04
($42.8)
$ 47.1610%Reduce -41.96%42,504
MRKLeon Cooperman 2012-12-31 Buy 0.44%$40.64 - $47.96
($44.65)
$ 47.166%New holding, 590000 sh.590,000
MRKJoel Greenblatt 2012-12-31 Add0.07%$40.64 - $47.96
($44.65)
$ 47.166%Add 74.07%73,234
MRKRay Dalio 2012-12-31 Buy 0.02%$40.64 - $47.96
($44.65)
$ 47.166%New holding, 44141 sh.44,141
MRKJohn Hussman 2012-12-31 Add$40.64 - $47.96
($44.65)
$ 47.166%Add 75%2,625
MRKJames Barrow 2012-12-31 Add$40.64 - $47.96
($44.65)
$ 47.166%Add 48.16%31,995
MRKJean-Marie Eveillard 2012-12-31 Add$40.64 - $47.96
($44.65)
$ 47.166%Add 55.25%14,050
MRKRuane Cunniff 2012-12-31 Sold Out -0.0018%$40.64 - $47.96
($44.65)
$ 47.166%Sold Out0
MRKJoel Greenblatt 2012-09-30 Add0.06%$41.2 - $45.24
($43.62)
$ 47.168%Add 99.54%42,072
MRKCharles Brandes 2012-09-30 Reduce-0.46%$41.2 - $45.24
($43.62)
$ 47.168%Reduce -30.5%2,421,576
MRKJean-Marie Eveillard 2012-09-30 Reduce-0.05%$41.2 - $45.24
($43.62)
$ 47.168%Reduce -97.17%9,050
MRKMario Gabelli 2012-09-30 Reduce-0.03%$41.2 - $45.24
($43.62)
$ 47.168%Reduce -32.69%221,193
MRKRuane Cunniff 2012-06-30 Reduce$37.21 - $41.08
($38.52)
$ 47.1622%Reduce -51.35%5,375
MRKJoel Greenblatt 2012-06-30 Reduce-0.02%$37.21 - $41.08
($38.52)
$ 47.1622%Reduce -21.56%21,085
MRKJoel Greenblatt 2012-03-31 Add0.07%$37.31 - $39.26
($35.99)
$ 47.1631%Add 358.41%26,881
MRKMario Gabelli 2012-03-31 Add0.03%$37.31 - $39.26
($35.99)
$ 47.1631%Add 46.56%326,221
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MRK James Barrow 2013-03-3112,483,5760.410.99+38917.3%
MRK Jean-Marie Eveillard 2013-03-311,537,9190.050.23+10846%
MRK Leon Cooperman 2013-03-311,921,3000.061.3+225.64%
MRK Ray Dalio 2013-03-3195,94100.04+117.35%
MRK Mario Gabelli 2013-03-31220,7640.010.06+13.26%
MRK Vanguard Health Care Fund 2013-03-3135,919,6481.196.3+1.21%
MRK John Hussman 2013-03-312,62500
MRK Prem Watsa 2013-03-318,00000.01
MRK Dodge & Cox 2013-03-3151,265,9461.72.8-2.26%
MRK Charles Brandes 2013-03-311,885,4130.060.98-6.41%
MRK Joel Greenblatt 2013-03-3142,50400.1-41.96%
Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
AMBROSE ADELE DSr.V-P & Chief Comuns Officer 2013-05-15Sell34,208$46.661.44view
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care 2013-05-13Sell5,404$46.152.56view
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care 2013-05-07Sell54,532$45.084.99view
Deese Willie AExe V-P & Pres. MMD 2013-05-06Sell36,204$45.24.71view
Kuhlik Bruce NExe V-P & Gen Counsel 2013-05-06Sell249,998$45.055.06view
Kuhlik Bruce NExe V-P & Gen Counsel 2012-11-12Sell61,380$44.027.52view
KIM PETER SExe V-P & Pres, MRL 2012-11-05Sell420,000$45.54.02view
Schechter Adam HEVP & Pres-Global Human Health 2012-11-05Sell56,300$45.63.79view
Deese Willie AExe V-P & Pres. MMD 2012-08-09Sell62,324$44.266.94view
Canan JohnSr.V-P Finc-Global Controller 2012-08-01Sell30,500$44.296.86view

Press Releases about MRK:

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
Leon Cooperman’s Bullish Buys: Linn Energy, Chimera Investment, Occidental Petroleum, Qualcomm, Me May 15 2013 
3 Dogs of the Dow With Highest Earnings Growth Apr 27 2013 
20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
3 Dogs of the Dow with the Highest Expected Earnings Growth Mar 27 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 22 2013 
Why Is Life (LIFE) Cheap? Mar 18 2013 
10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013 
My 3 Favorite Dogs of the Dow Jones Feb 26 2013 
2013: Breakout or Comeuppance? Jan 28 2013 
10-year Shiller P/E Exposes Cyclical Overvaluation and Undervaluation Jan 26 2013 

More From Our Partners
Merck Issues Update on Phase III Trial for Preladenant May 23 2013 - BENZINGA

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK